233 related articles for article (PubMed ID: 36437415)
21. The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities.
Hensen K; Van Valckenborgh IC; Kas K; Van de Ven WJ; Voz ML
Cancer Res; 2002 Mar; 62(5):1510-7. PubMed ID: 11888928
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.
Miller S; Rogers HA; Lyon P; Rand V; Adamowicz-Brice M; Clifford SC; Hayden JT; Dyer S; Pfister S; Korshunov A; Brundler MA; Lowe J; Coyle B; Grundy RG
Neuro Oncol; 2011 Aug; 13(8):866-79. PubMed ID: 21798848
[TBL] [Abstract][Full Text] [Related]
23. Embryonal tumors in the WHO CNS5 classification: A Review.
Gianno F; Miele E; Antonelli M; Giangaspero F
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
[TBL] [Abstract][Full Text] [Related]
24. hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors.
Fan X; Wang Y; Kratz J; Brat DJ; Robitaille Y; Moghrabi A; Perlman EJ; Dang CV; Burger PC; Eberhart CG
Am J Pathol; 2003 Jun; 162(6):1763-9. PubMed ID: 12759234
[TBL] [Abstract][Full Text] [Related]
25. Altered expression of the imprinted transcription factor PLAGL1 deregulates a network of genes in the human IUGR placenta.
Iglesias-Platas I; Martin-Trujillo A; Petazzi P; Guillaumet-Adkins A; Esteller M; Monk D
Hum Mol Genet; 2014 Dec; 23(23):6275-85. PubMed ID: 24993786
[TBL] [Abstract][Full Text] [Related]
26. Transcription Factor PLAGL1 Is Associated with Angiogenic Gene Expression in the Placenta.
Starks RR; Abu Alhasan R; Kaur H; Pennington KA; Schulz LC; Tuteja G
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171905
[TBL] [Abstract][Full Text] [Related]
27. The cell cycle control gene ZAC/PLAGL1 is imprinted--a strong candidate gene for transient neonatal diabetes.
Kamiya M; Judson H; Okazaki Y; Kusakabe M; Muramatsu M; Takada S; Takagi N; Arima T; Wake N; Kamimura K; Satomura K; Hermann R; Bonthron DT; Hayashizaki Y
Hum Mol Genet; 2000 Feb; 9(3):453-60. PubMed ID: 10655556
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
[TBL] [Abstract][Full Text] [Related]
29. Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion.
Andreiuolo F; Ferrone CK; Rajan S; Perry A; Guney E; Cham E; Giannini C; Toland A; Willard N; de Souza AS; Dazelle K; Chung HJ; Singh O; Conway K; Coley N; Dampier C; Abdullaev Z; Pratt D; Cimino PJ; Quezado M; Aldape K
Acta Neuropathol Commun; 2024 Mar; 12(1):42. PubMed ID: 38500181
[TBL] [Abstract][Full Text] [Related]
30. Pleomorphic adenoma gene-like 2 regulates expression of the p53 family member, p73, and induces cell cycle block and apoptosis in human promonocytic U937 cells.
Hanks TS; Gauss KA
Apoptosis; 2012 Mar; 17(3):236-47. PubMed ID: 22076304
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation.
Korshunov A; Okonechnikov K; Schmitt-Hoffner F; Ryzhova M; Sahm F; Stichel D; Schrimpf D; Reuss DE; Sievers P; Suwala AK; Kumirova E; Zheludkova O; Golanov A; Jones DTW; Pfister SM; Kool M; von Deimling A
Acta Neuropathol Commun; 2021 Feb; 9(1):20. PubMed ID: 33536079
[TBL] [Abstract][Full Text] [Related]
32. H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications?
Gessi M; Gielen GH; Hammes J; Dörner E; Mühlen AZ; Waha A; Pietsch T
J Neurooncol; 2013 Mar; 112(1):67-72. PubMed ID: 23354654
[TBL] [Abstract][Full Text] [Related]
33. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
Liu APY; Dhanda SK; Lin T; Sioson E; Vasilyeva A; Gudenas B; Tatevossian RG; Jia S; Neale G; Bowers DC; Hassall T; Partap S; Crawford JR; Chintagumpala M; Bouffet E; McCowage G; Broniscer A; Qaddoumi I; Armstrong G; Wright KD; Upadhyaya SA; Vinitsky A; Tinkle CL; Lucas J; Chiang J; Indelicato DJ; Sanders R; Klimo P; Boop FA; Merchant TE; Ellison DW; Northcott PA; Orr BA; Zhou X; Onar-Thomas A; Gajjar A; Robinson GW
Acta Neuropathol; 2022 Oct; 144(4):733-746. PubMed ID: 35982322
[TBL] [Abstract][Full Text] [Related]
34. MYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous system .
Gessi M; von Bueren A; Treszl A; zur Mühlen A; Hartmann W; Warmuth-Metz M; Rutkowski S; Pietsch T
Neuro Oncol; 2014 Jul; 16(7):924-32. PubMed ID: 24470553
[TBL] [Abstract][Full Text] [Related]
35. PLAGL2 promotes the proliferation and migration of gastric cancer cells via USP37-mediated deubiquitination of Snail1.
Wu L; Zhao N; Zhou Z; Chen J; Han S; Zhang X; Bao H; Yuan W; Shu X
Theranostics; 2021; 11(2):700-714. PubMed ID: 33391500
[No Abstract] [Full Text] [Related]
36. Involvement of PLAGL2 in activation of iron deficient- and hypoxia-induced gene expression in mouse cell lines.
Furukawa T; Adachi Y; Fujisawa J; Kambe T; Yamaguchi-Iwai Y; Sasaki R; Kuwahara J; Ikehara S; Tokunaga R; Taketani S
Oncogene; 2001 Aug; 20(34):4718-27. PubMed ID: 11498794
[TBL] [Abstract][Full Text] [Related]
37. Central Nervous System-type Neuroepithelial Tumors and Tumor-like Proliferations Developing in the Gynecologic Tract and Pelvis: Clinicopathologic Analysis of 23 Cases.
Murdock T; Orr B; Allen S; Ibrahim J; Sharma R; Ronnett BM; Rodriguez FJ
Am J Surg Pathol; 2018 Nov; 42(11):1429-1444. PubMed ID: 30074494
[TBL] [Abstract][Full Text] [Related]
38. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.
Sturm D; Orr BA; Toprak UH; Hovestadt V; Jones DTW; Capper D; Sill M; Buchhalter I; Northcott PA; Leis I; Ryzhova M; Koelsche C; Pfaff E; Allen SJ; Balasubramanian G; Worst BC; Pajtler KW; Brabetz S; Johann PD; Sahm F; Reimand J; Mackay A; Carvalho DM; Remke M; Phillips JJ; Perry A; Cowdrey C; Drissi R; Fouladi M; Giangaspero F; Łastowska M; Grajkowska W; Scheurlen W; Pietsch T; Hagel C; Gojo J; Lötsch D; Berger W; Slavc I; Haberler C; Jouvet A; Holm S; Hofer S; Prinz M; Keohane C; Fried I; Mawrin C; Scheie D; Mobley BC; Schniederjan MJ; Santi M; Buccoliero AM; Dahiya S; Kramm CM; von Bueren AO; von Hoff K; Rutkowski S; Herold-Mende C; Frühwald MC; Milde T; Hasselblatt M; Wesseling P; Rößler J; Schüller U; Ebinger M; Schittenhelm J; Frank S; Grobholz R; Vajtai I; Hans V; Schneppenheim R; Zitterbart K; Collins VP; Aronica E; Varlet P; Puget S; Dufour C; Grill J; Figarella-Branger D; Wolter M; Schuhmann MU; Shalaby T; Grotzer M; van Meter T; Monoranu CM; Felsberg J; Reifenberger G; Snuderl M; Forrester LA; Koster J; Versteeg R; Volckmann R; van Sluis P; Wolf S; Mikkelsen T; Gajjar A; Aldape K; Moore AS; Taylor MD; Jones C; Jabado N; Karajannis MA; Eils R; Schlesner M; Lichter P; von Deimling A; Pfister SM; Ellison DW; Korshunov A; Kool M
Cell; 2016 Feb; 164(5):1060-1072. PubMed ID: 26919435
[TBL] [Abstract][Full Text] [Related]
39. PLAGL2 increases adriamycin resistance and EMT in breast cancer cells by activating the Wnt pathway.
Li Y; Liu R; Han X; Xu W; Liu Y
Genes Genomics; 2023 Jan; 45(1):49-57. PubMed ID: 36399309
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
